James Stearns

James Stearns has extensive experience in various leadership roles across multiple organizations within the healthcare and investment sectors. As a Non Executive Director at Blueberry Therapeutics Ltd, Neurelis, Inc., Qureight, EYE TECH CARE, Destiny Pharma plc, and Monkey Puzzle Day Nurseries Ltd, James Stearns brings strategic oversight to these companies. In addition, James Stearns serves as Chief Investment Officer (International) for China Medical System Holdings Ltd and holds a Board Observer position at Acclaro Medical and Acticor Biotech. James Stearns is also involved with CMS Ventures as a member of the Investment Committee, contributing to investment decisions since April 2021.